{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:40:19Z","timestamp":1786466419433,"version":"build-2736575974"},"reference-count":44,"publisher":"American Chemical Society (ACS)","issue":"31","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["242300421125"],"award-info":[{"award-number":["242300421125"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["252300421141"],"award-info":[{"award-number":["252300421141"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA1802800"],"award-info":[{"award-number":["2024YFA1802800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA1802802"],"award-info":[{"award-number":["2024YFA1802802"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22205206"],"award-info":[{"award-number":["22205206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22407119"],"award-info":[{"award-number":["22407119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22507090"],"award-info":[{"award-number":["22507090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92357302"],"award-info":[{"award-number":["92357302"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Liver fibrosis, a major cause of morbidity in chronic liver diseases, lacks effective therapies. Activated hepatic stellate cells (HSCs) are a promising therapeutic target for liver fibrosis, as their transformation into myofibroblasts drives disease progression by excessively depositing an extracellular matrix. Despite its antifibrotic potential, sorafenib faces clinical challenges due to poor aqueous solubility and lack of HSC specificity. To overcome these challenges, we developed IGFIIR aptamer-functionalized liposomes loaded with sorafenib (Apt-Lipo-SF), aiming to facilitate targeted delivery of sorafenib to activated HSCs with the aid of the IGFIIR aptamer and to augment its antifibrotic efficacy. Our findings demonstrated that the aptamer-functionalized liposomes exhibited enhanced cellular uptake in LX-2 cells and Apt-Lipo-SF could effectively suppress HSC activation, with its antifibrotic efficacy superior to that of free sorafenib. Apt-Lipo-SF developed in this study significantly enhanced the antifibrotic effect through targeted delivery, providing a new strategy for the treatment of liver fibrosis.<\/jats:p>","DOI":"10.1021\/acs.langmuir.6c02044","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:03:56Z","timestamp":1785852236000},"page":"22678-22685","source":"Crossref","is-referenced-by-count":0,"title":["IGFIIR Aptamer-Functionalized\nLiposomes for Targeted\nDelivery of Sorafenib to Ameliorate Liver Fibrosis"],"prefix":"10.1021","volume":"42","author":[{"given":"Taotao","family":"Cai","sequence":"first","affiliation":[{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450052"]},{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runwen","family":"Qin","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehai","family":"Li","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450052"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Yao","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450052"]},{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450052"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengmin","family":"Fan","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450052"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengbo","family":"Wang","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450052"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiru","family":"Chen","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1364-6628","authenticated-orcid":true,"given":"Zhenzhen","family":"Guo","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1734-1251","authenticated-orcid":true,"given":"Liujun","family":"Xu","sequence":"additional","affiliation":[{"name":"Quzhou Affiliated Hospital of Wenzhou Medical University , , ,","place":["Quzhou, China, 324000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450052"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8770-8591","authenticated-orcid":true,"given":"Qiuxia","family":"Yang","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450052"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"issue":"7","key":"2026081111075712700_cit1","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab."},{"issue":"4","key":"2026081111075712700_cit2","doi-asserted-by":"publisher","first-page":"load021","DOI":"10.1093\/lifemeta\/load021","article-title":"Extracellular matrix\nremodelling\nin obesity and metabolic disorders","volume":"2","author":"Musale","year":"2023","journal-title":"Life Metab."},{"issue":"3","key":"2026081111075712700_cit3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms\nof liver fibrosis\nand its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol.\nHepatol."},{"issue":"10","key":"2026081111075712700_cit4","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in\nliver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"2026081111075712700_cit5","doi-asserted-by":"publisher","first-page":"loae029","DOI":"10.1093\/lifemeta\/loae029","article-title":"Potential therapeutic strategies for MASH: from preclinical to clinical\ndevelopment","volume":"3","author":"Xie","year":"2024","journal-title":"Life Metab."},{"issue":"7","key":"2026081111075712700_cit6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell\nactivation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2026081111075712700_cit7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target\nin liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Delivery Rev."},{"issue":"5","key":"2026081111075712700_cit8","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jhep.2024.10.044","article-title":"Multi-modal\nanalysis of human hepatic stellate cells\nidentifies novel therapeutic targets for metabolic dysfunction-associated\nsteatotic liver disease","volume":"82","author":"Kim","year":"2025","journal-title":"J. Hepatol."},{"issue":"4","key":"2026081111075712700_cit9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nbt1396","article-title":"Resolution of liver cirrhosis using vitamin\nA-coupled liposomes to deliver siRNA against a collagen-specific chaperone","volume":"26","author":"Sato","year":"2008","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"2026081111075712700_cit10","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.cmet.2020.04.011","article-title":"Low-Dose\nSorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic\nSteatohepatitis","volume":"31","author":"Jian","year":"2020","journal-title":"Cell Metab."},{"issue":"8","key":"2026081111075712700_cit11","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S1470-2045(22)00326-6","article-title":"Cabozantinib\nplus atezolizumab versus sorafenib for\nadvanced hepatocellular carcinoma (COSMIC-312): A multicentre, open-label,\nrandomised, phase 3 trial","volume":"23","author":"Kelley","year":"2022","journal-title":"Lancet Oncol."},{"issue":"1","key":"2026081111075712700_cit12","doi-asserted-by":"publisher","first-page":"10096","DOI":"10.1038\/s41467-025-65056-9","article-title":"Co-delivery\nof sorafenib and an FSP1 inhibitor triggers dual ferroptosis in tumor\ncells and immunosuppressive macrophages for enhanced immunotherapy\nin mouse models of hepatocellular carcinoma","volume":"16","author":"Tang","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"2026081111075712700_cit13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jhep.2010.02.027","article-title":"New insights\ninto the antifibrotic effects of sorafenib on hepatic stellate cells\nand liver fibrosis","volume":"53","author":"Wang","year":"2010","journal-title":"J. Hepatol."},{"issue":"1","key":"2026081111075712700_cit14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy\nand safety of sorafenib in patients in the\nAsia-Pacific region with advanced hepatocellular carcinoma: A phase\nIII randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol."},{"issue":"6137","key":"2026081111075712700_cit15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/329301a0","article-title":"Insulin-like\ngrowth factor II receptor\nas a multifunctional binding protein","volume":"329","author":"Morgan","year":"1987","journal-title":"Nature"},{"issue":"1","key":"2026081111075712700_cit16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/hep.20015","article-title":"Differential modulation\nof rat hepatic stellate phenotype by natural and synthetic retinoids","volume":"39","author":"Hellemans","year":"2004","journal-title":"Hepatology"},{"issue":"5","key":"2026081111075712700_cit17","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/hep.510290526","article-title":"Albumin modified with\nmannose 6-phosphate: A potential carrier for selective delivery of\nantifibrotic drugs to rat and human hepatic stellate cells","volume":"29","author":"Beljaars","year":"1999","journal-title":"Hepatology"},{"issue":"7","key":"2026081111075712700_cit18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/cbin.10085","article-title":"Enhanced activity of\nlysosomal proteases in activated rat hepatic\nstellate cells is associated with a concomitant increase in the number\nof the mannose-6-phosphate\/insulin-like growth factor II receptor","volume":"37","author":"Mousavi","year":"2013","journal-title":"Cell Biol. Int."},{"issue":"17","key":"2026081111075712700_cit19","doi-asserted-by":"publisher","first-page":"2212206","DOI":"10.1002\/adma.202212206","article-title":"Restoration of Sinusoid\nFenestrae Followed by Targeted Nanoassembly Delivery of an Anti-Fibrotic\nAgent Improves Treatment Efficacy in Liver Fibrosis","volume":"35","author":"Li","year":"2023","journal-title":"Adv. Mater."},{"issue":"1","key":"2026081111075712700_cit20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.nano.2017.08.017","article-title":"Development\nof a peptide-modified siRNA nanocomplex for hepatic stellate\ncells","volume":"14","author":"Zhao","year":"2018","journal-title":"Nanomedicine"},{"issue":"28","key":"2026081111075712700_cit21","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.2174\/092986707782794005","article-title":"Mannose 6-phosphate\nreceptor targeting and its applications\nin human diseases","volume":"14","author":"Gary-Bobo","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"2026081111075712700_cit22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.addr.2019.07.010","article-title":"Nanocarrier-based systems for targeted\nand site specific therapeutic delivery","volume":"144","author":"Majumder","year":"2019","journal-title":"Adv.\nDrug Delivery Rev."},{"issue":"1","key":"2026081111075712700_cit23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based\ndrug delivery systems: Recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol"},{"issue":"10","key":"2026081111075712700_cit24","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1038\/s41596-022-00713-7","article-title":"Nanocarriers\nbased on bacterial membrane\nmaterials for cancer vaccine delivery","volume":"17","author":"Zhao","year":"2022","journal-title":"Nat.\nProtoc."},{"issue":"16","key":"2026081111075712700_cit25","doi-asserted-by":"publisher","first-page":"2100876","DOI":"10.1002\/advs.202100876","article-title":"Multi-Functional\nLiposome: A Powerful Theranostic Nano-Platform Enhancing Photodynamic\nTherapy","volume":"8","author":"Cheng","year":"2021","journal-title":"Adv. Sci."},{"issue":"6","key":"2026081111075712700_cit26","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41565-024-01620-6","article-title":"Chimeric nanobody-decorated liposomes by self-assembly","volume":"19","author":"Rahman","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"28","key":"2026081111075712700_cit27","doi-asserted-by":"publisher","first-page":"2506746","DOI":"10.1002\/advs.202506746","article-title":"Development of a DNA\nAptamer-Based Approach to Noninvasively Image CAR-T Cells In Vivo\nand Traceless Enrichment In Vitro","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci."},{"issue":"19","key":"2026081111075712700_cit28","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1039\/D3SC00439B","article-title":"Aptamers 101: aptamer\ndiscovery and in vitro applications in biosensors and separations","volume":"14","author":"Yang","year":"2023","journal-title":"Chem. Sci."},{"issue":"31","key":"2026081111075712700_cit29","doi-asserted-by":"publisher","first-page":"16800","DOI":"10.1002\/anie.202008663","article-title":"Advances and\nChallenges in Small-Molecule DNA Aptamer Isolation, Characterization,\nand Sensor Development","volume":"60","author":"Yu","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"issue":"5","key":"2026081111075712700_cit30","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1002\/anie.202003563","article-title":"Nucleic Acid\nAptamers for Molecular Diagnostics and Therapeutics: Advances and\nPerspectives","volume":"60","author":"Li","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"issue":"19","key":"2026081111075712700_cit31","doi-asserted-by":"publisher","first-page":"12035","DOI":"10.1021\/acs.chemrev.0c01140","article-title":"Aptamer-Based Detection of Circulating\nTargets for Precision Medicine","volume":"121","author":"Wu","year":"2021","journal-title":"Chem. Rev."},{"issue":"50","key":"2026081111075712700_cit32","doi-asserted-by":"publisher","first-page":"34311","DOI":"10.1021\/jacs.4c06189","article-title":"Programmable Circular Multispecific Aptamer-Drug Engager to Broadly\nBoost Antitumor Immunity","volume":"146","author":"Chen","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"45","key":"2026081111075712700_cit33","doi-asserted-by":"publisher","first-page":"24506","DOI":"10.1021\/jacs.3c03899","article-title":"Covalent LYTAC Enabled by DNA Aptamers\nfor Immune Checkpoint Degradation Therapy","volume":"145","author":"Li","year":"2023","journal-title":"J.\nAm. Chem. Soc."},{"issue":"20","key":"2026081111075712700_cit34","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.7150\/thno.28949","article-title":"An Aptamer-Based Probe\nfor Molecular Subtyping of Breast Cancer","volume":"8","author":"Liu","year":"2018","journal-title":"Theranostics"},{"issue":"5","key":"2026081111075712700_cit35","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1053\/jhep.2001.28457","article-title":"Transforming growth factor \u03b2\nand the liver","volume":"34","author":"Bissell","year":"2001","journal-title":"Hepatology"},{"issue":"1\u20133","key":"2026081111075712700_cit36","doi-asserted-by":"publisher","first-page":"d793","DOI":"10.2741\/gressner","article-title":"Roles of TGF-beta in\nhepatic fibrosis","volume":"7","author":"Gressner","year":"2002","journal-title":"Front. Biosci."},{"issue":"3","key":"2026081111075712700_cit37","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jhep.2014.06.010","article-title":"Inhibition\nof fibronectin deposition improves experimental liver fibrosis","volume":"62","author":"Altrock","year":"2015","journal-title":"J. Hepatol."},{"issue":"4","key":"2026081111075712700_cit38","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3350\/cmh.2022.0068","article-title":"Auranofin attenuates\nhepatic steatosis\nand fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-\n\u03baB signaling pathways","volume":"28","author":"Lee","year":"2022","journal-title":"Clinical Mol. Hepatol."},{"key":"2026081111075712700_cit39","doi-asserted-by":"publisher","first-page":"155465","DOI":"10.1016\/j.phymed.2024.155465","article-title":"Esculin inhibits\nhepatic stellate cell activation and CCl(4)-induced liver fibrosis\nby activating the Nrf2\/GPX4 signaling pathway","volume":"128","author":"Xu","year":"2024","journal-title":"Phytomedicine"},{"issue":"12","key":"2026081111075712700_cit40","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.7150\/thno.19374","article-title":"Discovery\nof Aptamer Ligands for Hepatic Stellate Cells Using SELEX","volume":"7","author":"Chen","year":"2017","journal-title":"Theranostics"},{"key":"2026081111075712700_cit41","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.biopha.2017.01.107","article-title":"Sorafenib: A potential\ntherapeutic\ndrug for hepatic fibrosis and its outcomes","volume":"88","author":"Ma","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"2026081111075712700_cit42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/bcpt.12365","article-title":"The adverse effects of sorafenib\nin patients with advanced cancers","volume":"116","author":"Li","year":"2015","journal-title":"Basic Clin.\nPharmacol. Toxicol."},{"issue":"44","key":"2026081111075712700_cit43","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202308761","article-title":"Liposomal Enzyme Nanoreactors Based on Nanoconfinement for Efficient\nAntitumor Therapy","volume":"62","author":"Wang","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"issue":"9","key":"2026081111075712700_cit44","doi-asserted-by":"publisher","first-page":"11289","DOI":"10.1021\/acsami.3c18051","article-title":"Sorafenib-Encapsulated\nLiposomes to Activate Hypoxia-Sensitive Tirapazamine\nfor Synergistic Chemotherapy of Hepatocellular Carcinoma","volume":"16","author":"Zhao","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"}],"container-title":["Langmuir"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.langmuir.6c02044","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/langd5\/article-pdf\/42\/31\/22678\/66350123\/acs.langmuir.6c02044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/langd5\/article-pdf\/42\/31\/22678\/66350123\/acs.langmuir.6c02044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:43:43Z","timestamp":1786463023000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/langd5\/article\/42\/31\/22678\/5238055\/IGFIIR-Aptamer-Functionalized-Liposomes-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":44,"journal-issue":{"issue":"31","published-online":{"date-parts":[[2026,7,31]]},"published-print":{"date-parts":[[2026,8,11]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.langmuir.6c02044","relation":{},"ISSN":["0743-7463","1520-5827"],"issn-type":[{"value":"0743-7463","type":"print"},{"value":"1520-5827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}